Hudock Inc’s Exelixis EXEL Stock Holding History

Hudock Inc’s Portfolio EXEL Stock Details EXEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-100	Closed	-$2K	–	672
2018 Q1	$2K	Hold	100	–	–	﹤0.01%	590
2017 Q4	$3K	Hold	100	–	–	﹤0.01%	539
2017 Q3	$2K	Buy	+100	New	+$2.66K	﹤0.01%	572

Other funds holding EXEL

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

MCMC

Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Hudock Inc's EXEL Position: Q2 2018 in Review

Hudock Inc sold out of Exelixis (EXEL) in Q2 2018, closing a stake of 100 shares — an estimated $2K sold.

Hudock Inc first reported a position in EXEL in Q3 2017 and held it in 3 quarters. The position peaked at $3K in Q4 2017. 303 funds tracked by Wall St. Rank hold EXEL as of Q2 2018.

Hudock Inc reported no remaining Exelixis position as of Q2 2018 after selling out during the quarter.
Hudock Inc sold 100 Exelixis shares in Q2 2018, an estimated $2K.
Hudock Inc first reported a position in Exelixis in Q3 2017 and held it in 3 quarters.
Hudock Inc's Exelixis position peaked at $3K in Q4 2017.
303 funds tracked by Wall St. Rank held Exelixis as of Q2 2018.

Based on Hudock Inc's 13F filing for Q2 2018, filed 1 Aug 2018.